MedTrace Logo

THE EFFECT OF MOTIVATIONAL INTERVIEWING ON MENOPAUSE MYTHS AND POSTTRAUMATIC GROWTH IN POSTMENOPAUSAL WOMEN:RANDOMIZED CONTROLLED STUDY

NCT07596368 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2026-05-19

No results posted yet for this study

Summary

This randomized controlled study aims to evaluate the effect of motivational interviewing on menopause myths and posttraumatic growth in postmenopausal women. Participants will be randomly assigned to an intervention group receiving four weekly motivational interviewing sessions or a control group receiving usual care. Outcomes will be assessed before and after the intervention using validated scales.

Conditions

Interventions

BEHAVIORAL

Motivational interviewing

The researcher provided training on motivational interviewing techniques to be applied to the experimental group prior to the intervention. Women will be informed about the research, and those wishing to participate will be given a voluntary information form to read, and their verbal and written consent will be obtained. The client will be informed about the duration, number, and timing of the interviews before the start of the MG sessions. Each motivational interview session with the women in the experimental group is planned to last approximately 30-45 minutes. A total of four MG sessions will be conducted with the women in the experimental group, once a week. All sessions will be conducted by inviting the women to their family physician's office. During the MG sessions, counseling will be provided on topics related to the menopausal period in order to change the women's negative beliefs about menopause myths and to increase their post-traumatic growth levels after menopause.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2026-10-31
Completion
2026-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07596368 on ClinicalTrials.gov